mesh condition

Headache
Intelligence

Headache intelligence: 25 indexed trials, 3 recruiting studies, 22 sponsors across 36 countries.

⚗
25Indexed trials
↗
3Recruiting
▦
22Sponsors
◎
36Countries

Leading sponsors

Danish Headache Center30 recruiting
Pfizer20 recruiting
Dartmouth-Hitchcock Medical Center10 recruiting
Dr. Ram Manohar Lohia Hospital11 recruiting
Eli Lilly and Company10 recruiting
H. Lundbeck A/S10 recruiting
Headache Sciences Incorporated10 recruiting
Impax Laboratories, LLC10 recruiting
Janssen-Ortho LLC10 recruiting
Medical College of Wisconsin10 recruiting
NYU Langone Health10 recruiting
Neuromed IRCCS10 recruiting

Geographic activity

United States14trials
Denmark5trials
Czechia4trials
Spain4trials
Germany4trials
Israel3trials
Italy3trials
Netherlands3trials
United Kingdom3trials
France3trials
Austria2trials
Greece2trials

Leading interventions

AMG334 (70 mg) Pre-Filled Syringe (PFS)1trials
Current standard discharge educational intervention1trials
Dexmedetomidine1trials
Galcanezumab1trials
Glycopyrrolate1trials
Gray tinted spectacle lenses1trials
Hypoxia1trials
Internet-delivered CBT for Insomnia1trials
Internet-delivered CBT for Pain Management1trials
Internet-delivered Sleep Education1trials
L-kynurenine1trials
AMG3341trials

Methodology note

This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.